ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

16 Institutions Win NCI Awards for Phase I Trials

May 2, 2003

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

Evidence Reported That Silica Increase Risk Of Cancer

September 7, 1984

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

October 15, 1976

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974